<?xml version='1.0' encoding='utf-8'?>
<document id="15345660"><sentence text="Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats."><entity charOffset="42-55" id="DDI-PubMed.15345660.s1.e0" text="valproic acid" /><entity charOffset="60-70" id="DDI-PubMed.15345660.s1.e1" text="carbapenem" /><pair ddi="false" e1="DDI-PubMed.15345660.s1.e0" e2="DDI-PubMed.15345660.s1.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s1.e0" e2="DDI-PubMed.15345660.s1.e1" /></sentence><sentence text="The Ministry of Health and Welfare, Japan banned coadministration of carbapenems, such as panipenem/betamipron (PAPM), meropenem (MEPM), and valproic acid (VPA) because clinical reports have indicated that the coadministration caused seizures in epileptic patients due to lowered plasma levels of VPA"><entity charOffset="69-80" id="DDI-PubMed.15345660.s2.e0" text="carbapenems" /><entity charOffset="90-99" id="DDI-PubMed.15345660.s2.e1" text="panipenem" /><entity charOffset="100-110" id="DDI-PubMed.15345660.s2.e2" text="betamipron" /><entity charOffset="112-116" id="DDI-PubMed.15345660.s2.e3" text="PAPM" /><entity charOffset="119-128" id="DDI-PubMed.15345660.s2.e4" text="meropenem" /><entity charOffset="130-134" id="DDI-PubMed.15345660.s2.e5" text="MEPM" /><entity charOffset="141-154" id="DDI-PubMed.15345660.s2.e6" text="valproic acid" /><entity charOffset="156-159" id="DDI-PubMed.15345660.s2.e7" text="VPA" /><entity charOffset="297-299" id="DDI-PubMed.15345660.s2.e8" text="VPA" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e0" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e1" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e2" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e3" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e4" e2="DDI-PubMed.15345660.s2.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e4" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e4" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e4" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e4" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e5" e2="DDI-PubMed.15345660.s2.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e5" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e5" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e5" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e6" e2="DDI-PubMed.15345660.s2.e6" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e6" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e6" e2="DDI-PubMed.15345660.s2.e8" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e7" e2="DDI-PubMed.15345660.s2.e7" /><pair ddi="false" e1="DDI-PubMed.15345660.s2.e7" e2="DDI-PubMed.15345660.s2.e8" /></sentence><sentence text=" In this study, we have clarified the mechanism of the drug-drug interaction using PAPM, MEPM, and doripenem [S-4661; (+)-(4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[[(3S,5S)-5-[(sulfamoylamino)methyl]-3-pyrrolidinyl]thio]-1-azabicyclo[3"><entity charOffset="83-85" id="DDI-PubMed.15345660.s3.e0" text="PAPM" /><entity charOffset="89-91" id="DDI-PubMed.15345660.s3.e1" text="MEPM" /><pair ddi="false" e1="DDI-PubMed.15345660.s3.e0" e2="DDI-PubMed.15345660.s3.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s3.e0" e2="DDI-PubMed.15345660.s3.e1" /></sentence><sentence text="2" /><sentence text="0]hept-2-ene-2-caboxylic acid monohydrate], a newly synthesized carbapenem"><entity charOffset="0-42" id="DDI-PubMed.15345660.s5.e0" text="0]hept-2-ene-2-caboxylic acid monohydrate]" /><entity charOffset="64-74" id="DDI-PubMed.15345660.s5.e1" text="carbapenem" /><pair ddi="false" e1="DDI-PubMed.15345660.s5.e0" e2="DDI-PubMed.15345660.s5.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s5.e0" e2="DDI-PubMed.15345660.s5.e1" /></sentence><sentence text=" In vitro experiments using monkey liver slices suggested that the apparent synthetic rate of VPA glucuronide (VPA-G) increased in the presence of carbapenems"><entity charOffset="94-109" id="DDI-PubMed.15345660.s6.e0" text="VPA glucuronide" /><entity charOffset="111-116" id="DDI-PubMed.15345660.s6.e1" text="VPA-G" /><entity charOffset="147-158" id="DDI-PubMed.15345660.s6.e2" text="carbapenems" /><pair ddi="false" e1="DDI-PubMed.15345660.s6.e0" e2="DDI-PubMed.15345660.s6.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s6.e0" e2="DDI-PubMed.15345660.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s6.e0" e2="DDI-PubMed.15345660.s6.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s6.e1" e2="DDI-PubMed.15345660.s6.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s6.e1" e2="DDI-PubMed.15345660.s6.e2" /></sentence><sentence text=" However, no such increase was observed in the experiment using monkey liver microsomes" /><sentence text=" Although no increase of uridine 5'-diphosphate D-glucuronic acid was found in monkey liver slices in the presence of carbapenems, potent inhibitory activity of carbapenems for the hydrolysis of VPA-G was found in monkey and rat liver homogenate"><entity charOffset="25-65" id="DDI-PubMed.15345660.s8.e0" text="uridine 5'-diphosphate D-glucuronic acid" /><entity charOffset="118-129" id="DDI-PubMed.15345660.s8.e1" text="carbapenems" /><entity charOffset="161-172" id="DDI-PubMed.15345660.s8.e2" text="carbapenems" /><entity charOffset="195-205" id="DDI-PubMed.15345660.s8.e3" text="VPA" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e0" e2="DDI-PubMed.15345660.s8.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e0" e2="DDI-PubMed.15345660.s8.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e0" e2="DDI-PubMed.15345660.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e0" e2="DDI-PubMed.15345660.s8.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e1" e2="DDI-PubMed.15345660.s8.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e1" e2="DDI-PubMed.15345660.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e1" e2="DDI-PubMed.15345660.s8.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e2" e2="DDI-PubMed.15345660.s8.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s8.e2" e2="DDI-PubMed.15345660.s8.e3" /></sentence><sentence text=" In vivo hydrolysis of VPA-G was clearly shown by the existence of VPA in plasma after dosing of VPA-G to rats, and its inhibition by carbapenems was also clearly shown by the negligible levels of VPA in rat plasma after coadministration of carbapenems and VPA-G"><entity charOffset="67-70" id="DDI-PubMed.15345660.s9.e0" text="VPA" /><entity charOffset="197-200" id="DDI-PubMed.15345660.s9.e1" text="VPA" /><entity charOffset="241-252" id="DDI-PubMed.15345660.s9.e2" text="carbapenems" /><entity charOffset="257-262" id="DDI-PubMed.15345660.s9.e3" text="VPA-G" /><entity charOffset="23-27" id="DDI-PubMed.15345660.s9.e4" text="VPA" /><entity charOffset="97-101" id="DDI-PubMed.15345660.s9.e5" text="VPA" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e4" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e4" e2="DDI-PubMed.15345660.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e0" e2="DDI-PubMed.15345660.s9.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e0" e2="DDI-PubMed.15345660.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e0" e2="DDI-PubMed.15345660.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e0" e2="DDI-PubMed.15345660.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e0" e2="DDI-PubMed.15345660.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e5" e2="DDI-PubMed.15345660.s9.e5" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e5" e2="DDI-PubMed.15345660.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e5" e2="DDI-PubMed.15345660.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e5" e2="DDI-PubMed.15345660.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e1" e2="DDI-PubMed.15345660.s9.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e1" e2="DDI-PubMed.15345660.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e1" e2="DDI-PubMed.15345660.s9.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e2" e2="DDI-PubMed.15345660.s9.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s9.e2" e2="DDI-PubMed.15345660.s9.e3" /></sentence><sentence text=" These results clearly indicate one of the important causes of drug interaction as follows: carbapenems would inhibit the hydrolytic enzyme, which is involved in the hydrolysis of VPA-G to VPA, resulting in a decrease of plasma concentration of VPA"><entity charOffset="92-103" id="DDI-PubMed.15345660.s10.e0" text="carbapenems" /><entity charOffset="180-190" id="DDI-PubMed.15345660.s10.e1" text="VPA" /><entity charOffset="189-199" id="DDI-PubMed.15345660.s10.e2" text="VPA" /><entity charOffset="245-255" id="DDI-PubMed.15345660.s10.e3" text="VPA" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e0" e2="DDI-PubMed.15345660.s10.e0" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e0" e2="DDI-PubMed.15345660.s10.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e0" e2="DDI-PubMed.15345660.s10.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e0" e2="DDI-PubMed.15345660.s10.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e1" e2="DDI-PubMed.15345660.s10.e1" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e1" e2="DDI-PubMed.15345660.s10.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e1" e2="DDI-PubMed.15345660.s10.e3" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e2" e2="DDI-PubMed.15345660.s10.e2" /><pair ddi="false" e1="DDI-PubMed.15345660.s10.e2" e2="DDI-PubMed.15345660.s10.e3" /></sentence><sentence text="" /></document>